Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BTL-703

K-Number: K182363 · 2019-01-24

Decision Date2019-01-24
Product CodeIMJ
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

BTL-703 is a medical device manufactured by BTL Industries, Inc.. It received FDA 510(k) clearance on 2019-01-24 under approval number K182363. The device is classified under product code IMJ. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BTL-703?

BTL-703 is a medical device that received FDA 510(k) clearance on 2019-01-24. It is manufactured by BTL Industries, Inc.. The 510(k) number is K182363.

When was BTL-703 approved by the FDA?

BTL-703 received FDA 510(k) clearance on 2019-01-24, under approval number K182363.

What company makes BTL-703?

BTL-703 is manufactured by BTL Industries, Inc..

What is the FDA product code for BTL-703?

The FDA product code for BTL-703 is IMJ.

Other Devices by BTL Industries, Inc.

View all 33 devices →

Related Devices (Code: IMJ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.